Mi az ára Celltrion Healthcare Co., Ltd. (091990)

Celltrion Healthcare Co., Ltd. (091990) ára $57.75

Mi a Celltrion Healthcare Co., Ltd. (091990 piaci tőkésítése)

Celltrion Healthcare Co., Ltd. piaci tőkésítése (091990) $9.42B

Celltrion Healthcare Co., Ltd. (091990) Árfolyamtörténet

Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.

Év	Teljesítmény
2024	1.85%
2023	14.18%
2022	-28.39%
2021	0.00%

Év

Teljesítmény

2024

1.85%

2023

14.18%

2022

-28.39%

2021

0.00%

Vállalat	Részvényár	Változás 1év%	Ország
Vertex Pharmaceuticals Incorporated VRTX.US	$552.62	42.08%	US
Argenx SE ARGX.US	$1.02K	50.90%	NL
Moderna, Inc. MRNA.US	$155.33	512.75%	US
CSL Limited CSL.AX	$122.47	-12.71%	AU
Lonza Group AG LONN.SW	$772.27	8.67%	CH

Vállalat

Részvényár

Változás 1év%

Ország